Paul M. Stafford
University Health Network(CA)Krembil Research Institute
Publications by Year
Research Areas
Tryptophan and brain disorders, Stress Responses and Cortisol, Treatment of Major Depression, Neuroinflammation and Neurodegeneration Mechanisms, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → Alzheimer's disease as an autoimmune disorder of innate immunity endogenously modulated by tryptophan metabolites(2022)79 cited
- → Effects of the Novel IDO Inhibitor DWG-1036 on the Behavior of Male and Female 3xTg-AD Mice(2019)49 cited
- → A Retinoblastoma Allele That Is Mutated at Its Common E2F Interaction Site Inhibits Cell Proliferation in Gene-Targeted Mice(2014)36 cited
- → Identification of Potent Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors Based on a Phenylimidazole Scaffold(2018)32 cited
- → Susceptibility to hippocampal kindling seizures is increased in aging C57 black mice(2017)25 cited
- → A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl)methyl)‐1H‐indoles as Indoleamine 2,3‐Dioxygenase 1 (IDO1) Inhibitors(2021)11 cited
- → Development and Optimization of a Target Engagement Model of BrainIDO Inhibition for Alzheimer’s Disease(2023)2 cited
- → [P4–031]: ALZHEIMER'S DISEASE AS A DISORDER OF TRYPTOPHAN METABOLISM(2017)1 cited
- → Front Cover: A Series of 2‐((1‐Phenyl‐1H‐imidazol‐5‐yl)methyl)‐1H‐indoles as Indoleamine 2,3‐Dioxygenase 1 (IDO1) Inhibitors (ChemMedChem 14/2021)(2021)